13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000905148-24-001442
Total Value
$281.9M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $108.2M | 38.37% |
| 2 | PHARVARIS N V | PHVS | 4,289,304 | $99.1M | 35.17% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,035,396 | $34.8M | 12.33% |
| 4 | ACELYRIN INC | 00445A100 | 3,852,470 | $26.0M | 9.23% |
| 5 | ELEVATION ONCOLOGY INC | 28623U101 | 2,696,133 | $13.8M | 4.91% |